This edition of Medtech Insight’s Cardiovascular Catch-Up features highlights from recent interviews with leaders of some not-so-famous companies addressing cardiovascular health from a variety of angles – from improving the traditional stethoscope to non-invasive 3D mapping of arrhythmias and more.
[Editor's Note: The original version of this article misplaced egnite's headquarters in California. The company is based in Aliso Viejo in southern Orange County – not Silicon Valley. We regret the error and corrected this article on 23 June.]
Belfast-based B-Secur is rolling out HeartKey 2.0, cloud-based software that significantly reduces the noise in electrocardiograms (ECG or EKG) while improving the interpretation of EKGs to facilitate more effective remote...
Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
